Get the latest tech news

Breakthrough PTSD treatment achieves 68% remission rate in clinical trial


A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.

None

Get the Android app

Or read this on r/technology

Read more on:

Photo of Breakthrough

Breakthrough

Photo of clinical trial

clinical trial

Photo of % remission rate

% remission rate

Related news:

News photo

A look at the math that OpenAI claims computes faster Fourier transforms

News photo

Clinical trial of a prion disease drug candidate begins enrolling participants

News photo

Clinical Trial Indicates A.I. Chatbots Could Aid Urgent Care